Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Bungeon Dec 15, 2020 8:59am

238 Views

Post# 32107422

Random L2

Level 2 Quote

Level two quotes - Bid
Number of Shares		Bid Price
5,000 shares	5,000	0.230
25,000 shares	25,000	0.215
40,500 shares	40,500	0.210
5,000 shares	5,000	0.205
128,000 shares	128,000	0.200
65,000 shares	65,000	0.190
170,500 shares	170,500	0.185
42,500 shares	42,500	0.180
7,000 shares	7,000	0.170
33,000 shares	33,000	0.165

Level two quotes - Ask
Ask Price	Number of Shares
0.230	59,500	59,500 shares
0.235	42,500	42,500 shares
0.240	80,000	80,000 shares
0.245	49,500	49,500 shares
0.250	174,500	174,500 shares
0.255	4,000	4,000 shares
0.260	4,000	4,000 shares
0.265	80,000	80,000 shares
0.270	17,500	17,500 shares
0.275	12,000